Although PSMA-targeted radiotracers, such as 18F-PSMA-1007, offer enhanced sensitivity for detecting metastatic disease, their specificity can be compromised by benign PSMA-avid lesions, resulting in false positives [9,10]. The gene discussed is FOLH1; the disease is metastatic neoplasm.